Neurocrine Biosciences, Inc. Reports Third Quarter 2013 Results

Published: Oct 30, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and 

post your resume.

SAN DIEGO, Oct. 29, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended September 30, 2013. For the third quarter of 2013, the Company reported a net loss of $11.1 million, or $0.17 loss per share, compared to a net loss of $3.1 million, or $0.05 loss per share, for the same period in 2012. For the nine months ended September 30, 2013, the Company reported a net loss of $35.4 million, or $0.53 loss per share, as compared to net loss of $4.5 million, or $0.07 loss per share, for the first nine months of last year.

Help employers find you! Check out all the jobs and post your resume.

Back to news